60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON.
| Revenue (Most Recent Fiscal Year) | $0.30M |
| Net Income (Most Recent Fiscal Year) | $-7.95M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.34 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -617.39% |
| Net Margin (Trailing 12 Months) | -616.15% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -140.98% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.87 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.63 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 1.23 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-6.38 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.66 |
| Earnings per Share (Most Recent Fiscal Year) | $-18.55 |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 4.23M |
| Free Float | 4.16M |
| Market Capitalization | $4.32M |
| Average Volume (Last 20 Days) | 0.05M |
| Beta (Past 60 Months) | 2.82 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.69% |
| Percentage Held By Institutions (Latest 13F Reports) | 7.96% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |